• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

232.35 -5.93 (-2.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 777,840
Open 236.30
Bid (Size) 225.00 (100)
Ask (Size) 247.50 (100)
Prev. Close 238.28
Today's Range 229.16 - 238.00
52wk Range 125.78 - 266.38
Shares Outstanding 62,311,104
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cannabis Stocks: A Profitability Turnaround Is Brewing Beneath Weak Price Action ↗
September 22, 2026
Via Chartmill
Topics Cannabis
News headline image
Jazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1B ↗
September 20, 2026
Jazz Pharmaceuticals (NASDAQ:JAZZ) executives outlined the company’s oncology growth strategy, early commercial progress for recently launched therapies and business-development priorities during the... 
Via MarketBeat
Topics Cannabis

Performance

YTD
+34.2%
+34.2%
1 Month
-7.3%
-7.3%
3 Month
-3.6%
-3.6%
6 Month
+22.9%
+22.9%
1 Year
+80.1%
+80.1%

More News

Read More
News headline image
Jazz Pharmaceuticals Sees $3B-$5B Ziihera Opportunity as Pipeline Expands ↗
September 20, 2026
Via MarketBeat
Topics Cannabis
News headline image
Should You Buy Jazz Pharmaceuticals Stock After Its Actio Acquisition? ↗
September 18, 2026
Via The Motley Fool
Jazz Pharmaceuticals (NASDAQ:JAZZ): A Decent Value Stock Trading Below Its Worth ↗
September 02, 2026
Via Chartmill
Cannabis Rally Turns Selective as Investors Reward Pharma-Tinged Names ↗
August 29, 2026
Via Chartmill
Topics Cannabis
Jazz Pharmaceuticals (NASDAQ:JAZZ): A Decent Value Opportunity ↗
August 12, 2026
Via Chartmill
Cannabis Theme's Hidden Strength: Established Players Outshining Pure Plays ↗
July 30, 2026
Via Chartmill
Topics Cannabis
News headline image
3 Cash-Producing Stocks We’re Skeptical Of
September 11, 2026
Via StockStory
Topics Retirement
News headline image
2 Reasons to Avoid JAZZ and 1 Stock to Buy Instead
September 11, 2026
Via StockStory
Topics Stocks
News headline image
1 Value Stock with Exciting Potential and 2 We Brush Off
September 08, 2026
Via StockStory
Topics Energy Retirement
News headline image
Stocks making big moves yesterday: Jazz Pharmaceuticals, SAIC, Herbalife, AGCO, and Deere
September 01, 2026
Via StockStory
Cannabis Theme Rally Powered by Profitability, Not Pure-Play Speculation ↗
July 03, 2026
Via Chartmill
Topics Cannabis
Cannabis Stocks Split into Two Camps: Profitable Operators vs. High-Growth Speculation ↗
June 18, 2026
Via Chartmill
Topics Cannabis
News headline image
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
August 31, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Jazz Pharmaceuticals Launches Ziihera After FDA Nod in HER2-Positive GEA ↗
August 25, 2026
Via MarketBeat
Topics Cannabis
News headline image
3 Profitable Stocks with Questionable Fundamentals
August 14, 2026
Via StockStory
Topics Economy
News headline image
Jazz Pharmaceuticals (JAZZ) Q2 2026 Earnings Call Transcript ↗
August 10, 2026
Via The Motley Fool
Topics Earnings
News headline image
5 Revealing Analyst Questions From Jazz Pharmaceuticals’s Q2 Earnings Call
August 10, 2026
Via StockStory
Topics Earnings
News headline image
Jazz Pharmaceuticals Q2 Earnings Call Highlights ↗
August 03, 2026
Via MarketBeat
Topics Cannabis Earnings
News headline image
Jazz Pharmaceuticals (NASDAQ:JAZZ) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales
August 03, 2026
Via StockStory
News headline image
Jazz Pharmaceuticals (JAZZ) Q2 Earnings: What To Expect
August 02, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
3 Value Stocks with Open Questions
July 16, 2026
Via StockStory
News headline image
3 Overrated Stocks Walking a Fine Line
June 30, 2026
Via StockStory
News headline image
Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Here's Why the Stock Impact May Be More Limited Than It Looks ↗
June 23, 2026
Via The Motley Fool

Frequently Asked Questions

Is Jazz Pharmaceuticals plc - Ordinary Shares publicly traded?
Yes, Jazz Pharmaceuticals plc - Ordinary Shares is publicly traded.
What exchange does Jazz Pharmaceuticals plc - Ordinary Shares trade on?
Jazz Pharmaceuticals plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares?
The ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares is JAZZ on the Nasdaq Stock Market
What is the current price of Jazz Pharmaceuticals plc - Ordinary Shares?
The current price of Jazz Pharmaceuticals plc - Ordinary Shares is 232.35
When was Jazz Pharmaceuticals plc - Ordinary Shares last traded?
The last trade of Jazz Pharmaceuticals plc - Ordinary Shares was at 09/29/26 04:00 PM ET
What is the market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares?
The market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares is 14.48B
How many shares of Jazz Pharmaceuticals plc - Ordinary Shares are outstanding?
Jazz Pharmaceuticals plc - Ordinary Shares has 14B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap